trending Market Intelligence /marketintelligence/en/news-insights/trending/ixiygwetbxvbkidggqx_ug2 content esgSubNav
In This List

Acceleron Pharma appoints chief medical officer

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Acceleron Pharma appoints chief medical officer

Acceleron Pharma Inc. said July 5 that Robert Zeldin was appointed chief medical officer.

The Cambridge, Mass.-based biopharmaceutical company said Zeldin recently served as chief medical officer of Belgium-based Ablynx NV, now a unit of Sanofi.

Previously, Zeldin served as vice president and U.S. medical franchise head of respiratory and dermatology at Novartis AG's Novartis Pharmaceuticals and senior vice president and head of global clinical development at Stallergenes SA.